159 related articles for article (PubMed ID: 7002321)
1. Lotus tetragonolobus fucolectin as a potential model for "MIF-like" modulation of macrophage function: comparison of the interaction of Lotus fucose binding protein (FBP) and migration inhibitory factor (MIF) with macrophages in the migration inhibition assay.
Leu RW; Whitley SB; Herriott J; Huddleston DJ
Cell Immunol; 1980 Jul; 52(2):414-28. PubMed ID: 7002321
[No Abstract] [Full Text] [Related]
2. Binding characteristics of fluoresceinated Lotus tetragonolobus fucolectin to macrophage populations which are either responsive or refractory to activation by lymphokine.
Leu RW; Herriott MJ; Webb CF
Immunobiology; 1985 Apr; 169(3):272-9. PubMed ID: 3888826
[TBL] [Abstract][Full Text] [Related]
3. Interaction of Lotus-tetragonolobus Lectin (LTL) and an MIF-like factor with guinea-pig macrophages. I. Effects on macrophage migration inhibition and receptor-binding studies.
Fahlbusch B; Wollweber L; Drössler K; Scherbaum I; Zschiesche W
Immunobiology; 1982 Aug; 162(3):251-64. PubMed ID: 6752005
[TBL] [Abstract][Full Text] [Related]
4. Similarities in enhanced glucosamine incorporation by macrophages stimulated with migration inhibitory factor and the fucolectin from Lotus tetragonolobus.
Leu RW; Brewer MA; Huddleston DJ
Cell Immunol; 1980 Sep; 55(1):227-35. PubMed ID: 7000375
[No Abstract] [Full Text] [Related]
5. Different effect of (L)-fucose binding lectin on macrophage migration inhibition caused by guinea pig migration inhibitory factor and synthetic muramyl dipeptide.
Homma Y; Onozaki K; Hashimoto T; Miura K; Nagao S; Tanaka A
Int Arch Allergy Appl Immunol; 1981; 65(1):27-33. PubMed ID: 7012040
[TBL] [Abstract][Full Text] [Related]
6. Requirement for alpha-L-fucose on the macrophage membrane receptor for MIF.
Remold HG
J Exp Med; 1973 Nov; 138(5):1065-76. PubMed ID: 4583070
[TBL] [Abstract][Full Text] [Related]
7. Macrophages migration inhibition by complement activators, migration inhibitory factor, and Lotus fucolectin: evidence for common involvement of cell-associated esterase activity.
Leu RW; Herriott MJ
Cell Immunol; 1982 Apr; 68(2):302-10. PubMed ID: 7046953
[No Abstract] [Full Text] [Related]
8. Decreased Fc and C3 receptor function in macrophage populations which are refractory to migration inhibitory factor, C3 activators, and immune complex.
Leu RW; Hefley SM; Herriott MJ
Cell Immunol; 1983 Aug; 80(1):31-42. PubMed ID: 6347401
[TBL] [Abstract][Full Text] [Related]
9. Macrophage migration inhibition factor (MIF): reducing the variables.
MacSween JM; Rajaraman K; Rajaraman R; Fox RA
J Immunol Methods; 1982; 52(1):127-36. PubMed ID: 6288804
[TBL] [Abstract][Full Text] [Related]
10. Characterization of Lotus tetragonolobus fucolectin components for differences in hemagglutinating and macrophage activating activities.
Leu RW; Herriott MJ; Worley DS
Immunobiology; 1985 Apr; 169(3):250-62. PubMed ID: 3997198
[TBL] [Abstract][Full Text] [Related]
11. Further characterization of the putative glycolipid receptor for MIF: role of fucose associated with an acidic glycolipid.
Higgins TJ; Liu DY; Remold HG; David JR
Biochem Biophys Res Commun; 1980 Apr; 93(4):1259-65. PubMed ID: 6994721
[No Abstract] [Full Text] [Related]
12. Cell surface receptors for lymphokines. II. Studies on the carbohydrate composition of the MIF receptor on macrophages using synthetic saccharides and plant lectins.
Poste G; Allen H; Matta KL
Cell Immunol; 1979 Apr; 44(1):89-98. PubMed ID: 378419
[No Abstract] [Full Text] [Related]
13. Macrophage migration inhibition induced by MDP, LPS, PMA, and MIF/MAF: reversal by macrophage migration enhancement factor (MEF), L-fucose, L-fucosyl BSA, D-mannose, and D-mannosyl BSA.
Gordon MR; Chida K; Takata I; Myrvik QN
J Leukoc Biol; 1987 Sep; 42(3):197-203. PubMed ID: 3305746
[TBL] [Abstract][Full Text] [Related]
14. Role of macrophage activation on the response to migration inhibitory factor (MIF).
Leu RW; Woodson PD; Whitley SB
J Reticuloendothel Soc; 1977 Oct; 22(4):329-40. PubMed ID: 336882
[No Abstract] [Full Text] [Related]
15. The mechanism of action of soluble lymphocyte mediators. VI. Effect of migration inhibitory factor (MIF) on macrophage microtubules.
Pick E; Honig S; Griffel B
Int Arch Allergy Appl Immunol; 1979; 58(2):149-59. PubMed ID: 370028
[TBL] [Abstract][Full Text] [Related]
16. Reactivity to fucose-binding proteins of Lotus tetragonolobus correlates with metastatic phenotype of transitional cell carcinoma of the bladder.
Shirahama T; Ikoma M; Muramatsu H; Muramatsu T; Ohi Y
J Urol; 1992 Jun; 147(6):1659-64. PubMed ID: 1350644
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of action of migration inhibitory factor (MIF). I. Evidence for a receptor for MIF present on the peritoneal macrophage but not on the alveolar macrophage.
Leu RW; Eddleston AL; Hadden JW; Good RA
J Exp Med; 1972 Sep; 136(3):589-603. PubMed ID: 4115133
[TBL] [Abstract][Full Text] [Related]
18. Studies on the interaction of macrophage inhibitory factor (MIF) with the macrophage.
Remold HG
Clin Immunol Immunopathol; 1975 Nov; 4(4):573-6. PubMed ID: 1106928
[No Abstract] [Full Text] [Related]
19. Agglutination of murine and guinea pig peritoneal cells by alpha-L-fucose-binding lectin: Evonymus europaea.
Petryniak J; Duś D; Podwińska J
Eur J Immunol; 1983 Jun; 13(6):459-64. PubMed ID: 6861874
[TBL] [Abstract][Full Text] [Related]
20. Macrophage receptors for migration inhibitory factor (MIF), migration stimulatory factor (MSF), and agglutinating factor.
Fox RA; Gregory DS; Feldman JD
J Immunol; 1974 May; 112(5):1867-72. PubMed ID: 4594418
[No Abstract] [Full Text] [Related]
[Next] [New Search]
